Please assess the completion status of the following clinical trial:

Trial Title: rhuFVIIa in Post-partum Hemorrhage

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Severe postpartum hemorrhage, i.e non responsive to sulprostone infusion~Exclusion Criteria:~* \< 18 years~* personal antecedent of arterial or venous thrombosis~* written informed consent not approved/signed by the patient or her husband

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: f

Study Arms:
- Standard care for post-partum hemorrhage (Type: ACTIVE_COMPARATOR): The patients included in this arm of the study will recieve standard care for post-partum hemorrhage.
- rFVIIa (Type: EXPERIMENTAL): The patients included in this arm of the study will recieve standard care for post-partum hemorrhage plus a slow intravenous injection (2ml/min) of rFVIIa (60µg/kg)

Based on this trial design, predict the completion outcome and termination type (if applicable).